When FDA fines become the cost of doing business

A recent $3 billion settlement between drug giant GlaxoSmithKline and the FDA really got me thinking. On one hand, it’s a breathtakingly huge number, breaking the old record of $2.3 billion set by Pfizer a couple years back.  And there are some initial indications that the pharmas may be cleaning up their act a bit, expanding their compliance departments and reining in their sales forces in order to avoid …

Read more…